Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe
Inflammation after Adenoviral Gene Therapy by Seppelt, Philipp Christian et al.
RESEARCH ARTICLE
Loss of Endothelial Barrier in Marfan Mice
(mgR/mgR) Results in Severe Inflammation
after Adenoviral Gene Therapy
Philipp Christian Seppelt1☯*, Simon Schwill1☯, Alexander Weymann1, Rawa Arif1,
Antje Weber1, Marcin Zaradzki1, Karsten Richter2, Stephan Ensminger3, Peter
Nicholas Robinson4,5, Andreas H. Wagner6, Matthias Karck1, Klaus Kallenbach1
1 Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany, 2 German Cancer
Research Center, Division of Molecular Genetics, Heidelberg, Germany, 3 Heart and Diabetes Center NRW,
Clinic for Thoracic and Cardiovascular Surgery, Bad Oeynhausen, Germany, 4 Institute for Medical Genetics
and Human Genetics, Charité University Hospital, Berlin, Germany, 5 Max-Planck Institute for Molecular
Genetics and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany, 6 Institute of
Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany




Marfan syndrome is an autosomal dominant inherited disorder of connective tissue. The
vascular complications of Marfan syndrome have the biggest impact on life expectancy.
The aorta of Marfan patients reveals degradation of elastin layers caused by increased pro-
teolytic activity of matrix metalloproteinases (MMPs). In this study we performed adenoviral
gene transfer of human tissue inhibitor of matrix metalloproteinases-1 (hTIMP-1) in aortic
grafts of fibrillin-1 deficient Marfan mice (mgR/mgR) in order to reduce elastolysis.
Methods
We performed heterotopic infrarenal transplantation of the thoracic aorta in female mice (n
= 7 per group). Before implantation, mgR/mgR and wild-type aortas (WT, C57BL/6) were
transduced ex vivo with an adenoviral vector coding for human TIMP-1 (Ad.hTIMP-1) or β-
galactosidase (Ad.β-Gal). As control mgR/mgR and wild-type aortas received no gene ther-
apy. Thirty days after surgery, overexpression of the transgene was assessed by immuno-
histochemistry (IHC) and collagen in situ zymography. Histologic staining was performed to
investigate inflammation, the neointimal index (NI), and elastin breaks. Endothelial barrier
function of native not virus-exposed aortas was evaluated by perfusion of fluorescent albu-
min and examinations of virus-exposed tissue were performed by transmission electron
microscopy (TEM).
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Results
IHC and ISZ revealed sufficient expression of the transgene. Severe cellular inflammation
and intima hyperplasia were seen only in adenovirus treated mgR/mgR aortas (Ad.β-Gal,
Ad.hTIMP-1 NI: 0.23; 0.43), but not in native and Ad.hTIMP-1 treated WT (NI: 0.01; 0.00).
Compared to native mgR/mgR and Ad.hTIMP-1 treatedWT aorta, the NI is highly significant
greater in Ad.hTIMP-1 transduced mgR/mgR aorta (p = 0.001; p = 0.001). As expected,
untreated Marfan grafts showed significant more elastolysis compared to WT (p = 0.001).
However, elastolysis in Marfan aortas was not reduced by adenoviral overexpression of
hTIMP-1 (compared to untreated Marfan aorta: Ad.hTIMP-1 p = 0.902; control Ad.β-Gal. p =
0.165). The virus-untreated and not transplanted mgR/mgR aorta revealed a significant
increase of albumin diffusion through the endothelial barrier (p = 0.037). TEM analysis of
adenovirus-exposed mgR/mgR aortas displayed disruption of the basement membrane
and basolateral space.
Conclusions
Murine Marfan aortic grafts developed severe inflammation after adenoviral contact. We
demonstrated that fibrillin-1 deficiency is associated with relevant dysfunction of the endo-
thelial barrier that enables adenovirus to induce vessel-harming inflammation. Endothelial
dysfunction may play a pivotal role in the development of the vascular phenotype of Marfan
syndrome.
Introduction
In patients with Marfan Syndrome (MFS) mutation of the fibrillin-1 gene (FBN1) leads to
defective extracellular microfibrils, resulting in divergence and instability of the entire connec-
tive tissue [1]. Although MFS is a systemic disorder affecting the skeletal system, eyes, dura,
and pulmonary system, reduced life expectancy is primarily determined by cardiovascular
manifestations [2]. On the molecular level, there is a distinctive fragmentation of elastic fiber
networks (elastolysis) that results in increased aortic stiffness and pulse wave velocity as main
contributors for aortic dilatation [3]. Thus, dilatation of the aortic root is characteristic for
MFS and can lead to acute dissection of the aorta [4]. Today, prophylactic replacement of the
dilated aortic root with preservation of the native aortic valve leads to excellent results, allowing
an almost normal life expectancy [5, 6]. However, prevention of root dilatation by new thera-
peutic targets must be the ultimate therapeutic aim for patients with MFS.
Degradation of elastin fibers correlates with calcification of aortic media, recruitment of
inflammatory cells and overexpression of matrix metalloproteinases (MMPs) [7], [8]. MMPs
play a crucial role in degradation and modification of the extracellular matrix [9]. The most sig-
nificant endogenous inhibitors of MMPs are tissue inhibitor of matrix metalloproteinases
(TIMPs). TIMP-1 is a glycoprotein and represents a potent inhibitor of collagenases, gelatinases,
and proteoglycanases [10, 11]. It inhibits the activity of a wide range of MMPs and has been suc-
cessfully applied in disease models triggered by MMP-overexpression and hyperactivity [12,
13]. Forough et al. revealed increased elastin accumulation in the intima of rat carotids after
local overexpression of TIMP-1 [14]. The fibrillin-1 deficient mouse (mgR/mgR) represents an
accepted murine model of MFS with a strong genotype-phenotype correlation [15, 16]. The
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mgR/mgR mouse shows typical morphological features of MFS and die of spontaneous dissec-
tions of aortic root aneurysms [17]. Furthermore increased activity of MMP-2 andMMP-9 was
detected in the aortic wall of Marfan mice and application of the non-specific MMP-inhibitor
doxycycline has proved its potential to reduced progression of aneurysm formation in the mgR/
mgR as well as in a different Marfan mouse model based on a cysteine substitution in fibrillin-1
(Fbn1C1039G/+) [16, 18]. Therefore, the mgR/mgR mouse model is well suited for studying
new molecular strategies for the treatment of MFS.
In this work we report on the adenoviral mediated gene transfer of hTIMP-1 in mgR/mgR
mice with the goal of reducing MMP triggered elastolysis and stabilizing the aortic wall. As
study model we chose heterotopic transplantation of the thoracic aorta into an abdominal posi-
tion, which allows a safe and sufficient ex vivo adenoviral transduction of the aortic vessel
between harvest and transplantation. In contrast to systemic application of the adenovirus over
a tail vein unknown side effects can be limited and the effect of the transgene overexpression
can be observed directly by ex vivo transduction. Objectives of this work were first the proof of
feasibility of adenoviral gene therapy directed against elastolysis in Marfan mice and second to




Wildtype (WT) C57BL/6 and homozygous mgR/mgR Marfan mice (C57BL/6 genetic back-
ground) at the age of 6–9 weeks were used for this study. Because female mgR/mgR mice are
more robust than male and have shown a longer mean survival only female mice were used for
surgery. This study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The
protocol was approved by local administration (Regierungspräsidium Karlsruhe, permit num-
ber: T36/08, T 07/11 and G17/09). According to requirements by local administration and in
order to reduce the size of the animal breeding age of operated mice ranged between 6 to 9
weeks. All efforts were made to minimize suffering. Heterozygous females (mgR/-) were
matched with homozygous males (mgR/mgR) to generate adequate quantity of homozygous
mice. Wildtype mice were generated out of the same breed by breeding heterozygous (mgR/-)
mice. For genotyping tag DNA was isolated and analyzed by quantitative real-time polymerase
chain reaction as described before [17].
Adenoviral Vectors
Adenovirus was generated by Harald A. Fernandez (New York University Medical Center) and
Klaus Kallenbach. For this project we used adenovirus type 5, which lacks the E1A region and
is therefore replication incompetent [19],[20]. Adenovirus vectors coding for human TIMP-1
(Ad-CMVhTIMP-1) and β-galactosidase (Ad-CMVβ-Gal.) were produced, purified and fil-
trated in N52.E6 cells according to standard protocols as described previously [19, 20], [21].
Virus titer was determined by TCID (tissue-culture-infective-dose)-test in A549 cells and repli-
cation competence was ruled out by RCA (replication-competent-adenovirus)-test in A549
cells as well [22], [21]. Suitable virus titer was selected by determination of transduction effi-
ciency in Ad.hTIMP-1 transduced HEK-293 cells and Ad.β-Gal. transduced WT aortas (not
part of this work). Virus concentration of 5x109 pfu/ml presented the best ratio of transgene
expression and virus toxicity. The used Ad.hTIMP-1 has proofed its potential to transduce
human smooth muscle cells in vitro with high efficiency [22].
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Cell Culture
N52.E6 cells for cultivation of adenovirus, A549 cells for TCID-test and HEK 293 cells for west-
ern blotting were stored at -80°C. For cultivation cells were transferred either in D-MEM (HEK
293 and A549) or in alpha MEM (for N52.E6 cells) concentrated with 10% fetal calf serum, 1%
glutamine, 0,1mg/ml penicillin and 0,1mg/ml streptomycin (Invitrogen Life technologies
Corp., Carlsbad, USA). Cell medium was seeded and incubated at 37°C with 95% humidity and
5% CO2. At regular intervals cell culture were checked until a confluent cell lawn was format-
ted. Then cell medium was removed and the cells were washed with 5ml PBS and incubated
with 3ml trypsin (0,25%, Carl Roth GmbH, Karlsruhe, Germany) for 3min. Generated cell titer
was count in a Neubauer chamber (Neubauer improved counting chamber, Carl Roth GmbH,
Karlsruhe Germany).
Surgery
Overall 14 female WT mice and 21 female mgR/mgR mice at the age of 6–9 weeks underwent
heterotopic transplantation of the thoracic aorta into an infrarenal position. Donor mice of the
same age were euthanatized with CO2 and the abdomen was opened by median thoracotomy.
The left ventricle was punctured and 10 ml of cold saline solution (4°C, 0,9%, Braun AG, Mel-
sungen, Germany) was applied systemically. The thoracic aorta was dissected carefully and
removed en bloc. Depending on the experimental group the graft was now either first trans-
duced (see below) or only flushed with cold saline before transplantation. Recipient mice were
narcotized with isoflurane and the abdomen was opened by median laparotomy. The intestines
were mobilized and stored on wet gauze. The infrarenal aorta was then separated carefully
from the inferior vena cava and para-aortic tissue. Before the aorta was cut transversely, vessel
clips were set distal to the left renal artery and close to the bifurcation. The previously prepared
donor aorta was then implanted with each 5 to 6 simple interrupted stitches by the end-to-end
technique (Prolene 11–0, Nylon black, S&T AG, Neuhausen, Switzerland). To prevent distal
ischemia the lower limbs were consistently cooled with cold saline solution. After finishing the
anastomoses clips were removed and bleeding control was started. Thereafter, the intestines
were repositioned and the abdomen and skin were closed by continuous stitches. Neither sys-
temic nor local anticoagulation was used perioperatively. The postoperative protocol included
mobilization and massage of lower limbs to guarantee distal perfusion and analgesia every
eight hours for three consecutive days (Buprenorphine, 0.05mg / kg body weight). Grafts were
harvested 30 days post-surgery.
Adenoviral Transduction
For adenoviral transduction, the ascending aorta was cannulated with a blunt cannula and two
knots were set to secure positioning within the aorta. The aorta was clipped distally and inocu-
lum injected for incubation. In addition the aorta was placed within the virus solution for 5
minutes to obtain virus transduction from the adventitial side as well. In order to increase
transduction efficiency, adenovirus was dissolved in Poloxamer 407 (21%, BASF, Ludwigsha-
fen, Germany). After 30 minutes in 37°C incubation solution (Dulbecco's Modified Eagle's
Medium, DMEM 2%, 10% fetal calf serum, FCS), the clip was removed and the aorta was
flushed several times with cold saline solution for complete removal of virus solution. Aortic
grafts of mgR/mgR mice (n = 7) and WTmice (n = 7) were treated with 1 ml adenoviral vector
solution coding for hTIMP-1 (Ad.hTIMP-1, 5x109 pfu/ml). Furthermore, mgR/mgR mice
(n = 7) were treated by vector coding for β-galactosidase (1 ml, Ad.β-Gal., 5x109 pfu/ml) to
evaluate transfection. Finally, mgR/mgR (n = 7) and WTmice (n = 7) did not receive any
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perioperative adenoviral treatment and were simply flushed with cold saline and incubated
after the same protocol.
Western Blotting
Western blotting was accomplished to show overexpression of human TIMP-1 protein after
transduction with Ad-hTIMP-1. Therefore HEK-293 cells were transduced (60min, 5x109 pfu/
ml) and cell supernatant was centrifugalized after standard protocols for protein isolation. Pro-
tein concentration was measured photometrically by Bradford protein assay (Dye-Reagent-
Concentrate, Bio-Rad Laboratories GmbH, München, Germany; Hitach U200, Hitachi Ltd.,
Tokyo, Japan) Proteins were separated by SDS (sodium dodecyl sulfate) polyacrylamide gel
electrophoresis (ready-made gels, Invitrogen, Life technologies Corp., Carlsbad, USA; broad
range protein marker, New England Biolabs, Ipswich, USA) and transferred by western blot-
ting on a polyvinylidene fluoride membrane at 50 volt using a standard blot chamber (Invitro-
gen Life Technologies Corp., Carlsbad, USA). After overnight blocking in phosphate buffered
saline (PBS solution) blot membrane was incubated with primary (three hours, 1:1000 in PBS,
human TIMP-1 antibody, MAB 3301, Merck Millipore, Darmstadt, German) and secondary
antibody (one hour, 1:5000 in PBS, horse radish peroxidase linked, AP 308P, Merck Millipore,
Darmstadt, Germany). Finally, secondary antibody was detected to determine protein lanes
(Fujifilm film cassette, Tokyo, Japan; ECL Plus Western Blotting Detection reagent, GE Health-
care Amershan, USA).
Human TIMP-1 Immunohistochemistry
Immunohistochemical staining was performed on aortic grafts 30 days post transplantation to
verify overexpression of human TIMP-1 after transduction of Ad.h-TIMP-1 prior to transplan-
tation. Monoclonal murine antibody against human TIMP-1 was applied to aortic cryo-sec-
tions (human TIMP-1 antibody, MAB3301, Merck Millipore, Darmstadt, Germany) for 30
min at a dilution of 1:200 and visualized by secondary antibody labeled with horseradish perox-
idase according to the manufacturer’s protocols (PK-2200, SP-2001 und Sk-4100, Vector Labo-
ratories Inc., Burlingame, USA). Evaluation was performed by bright-field microscopy (Nikon
Ni-E, Nikon Imaging Center, Nikon Imaging Software 4.6, Nikon, Tokyo, Japan).
F4/80 Monocytes Fluorescence Immunohistochemistry
In order to outline cellular inflammation 30 days post transplantation immunofluorescence
staining of frozen tissue sections was performed according to standard protocols. Rat anti-
mouse F4/80 antibody against monocytes (T-2006, 1:200 dilution) was obtained from Dianova
(Hamburg, Germany) and goat anti-human IgG-Cy3 was obtained from Sigma-Aldrich as sec-
ondary antibody (Taufkirchen, Germany). Cell nuclei were visualized by counterstaining with
DAPI and fluorescence intensity was recorded using an Olympus IX81 confocal microscope
(Olympus, Japan). Qualitative image analyses were performed using the Olympus Xcellence
software (Olympus, Japan).
Albumin Perfusion Test
In order to verify endothelial integrity, 6 native, not virus-exposed and not transplanted mgR/
mgR aortas and 6 native, not virus-exposed and not transplanted WT aortas were perfused
with fluorochrome labeled albumin (100μg/ml albumin from bovine serum, Alexa Fluor1 594
conjugate Molecular Probes, Inc. Eugene, USA diluted in PBS) and after 30 minutes of incuba-
tion flushed accurately with cold saline. For statistical evaluation aortas were cut, cryofixed and
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analyzed in 200x magnification by fluorescent microscopy (Texas Red, absorptions maxima of
586nm and fluorescence emissions maxima of 605nm, Nikon Ni-E, Nikon Imaging Center
Heidelberg, Nikon, Tokyo, Japan). The aortic media was defined as region of interest (ROI)
and was selected semi-automatically by imaging software (Nikon Imaging Software 4.6, Nikon,
Tokyo, Japan). To rule out systemic evaluation errors, in total 9 photos of each aortic media
were taken in different parts of the aorta and mean of relative brightness was calculated for
each media.
Collagen In Situ Zymography
Activity of MMP-1, 2, 3, 9, and 13 within the tissue was visualized by collagen in situ zymogra-
phy. Thirty days after transplantation grafts were harvested and cryofixed slides (5mm cut) of
the aorta were covered and incubated with fluorescent proteinase substrate (dq-collagen,
EnzCheck D-12060, Molecular Probes, Invitrogen, Carlsbad, USA) for 48h according to manu-
facturer’s instructions. Prior and after incubation pictures were taken with identical camera set-
tings and matched for analysis. Differences in light emission as the result of collagen substrate
conversion were analyzed by fluorescent microscopy. Dq-collagen has absorptions maxima of
495nm and fluorescence emissions maxima of 515nm.
Microscopic Examination
Mice were euthanized with CO2 for graft examination 30 days post-surgery. Before graft
explantation the heart was punctured and cold saline (4°C) was perfused systemically. For his-
tologic examination aortas were cryofixed (Tissue-Tek1O.C.T™ Compound, Sakura Finetek,
Netherlands) and cut in 5-mm frozen sections. The graft was divided into 4 parts A to D (6–9
slices per part) to ensure a continuous evaluation. To analyze intimal hyperplasia, elastin
breaks and inflammation Elastica van Gieson and Hematoxylin-Eosin staining was performed.
Pictures were taken at 100x and 400x magnification (Nikon Eclipse 90i; Nikon Imaging Center,
Heidelberg, Germany) and assessed by common imaging software (Image Pro Plus 4.5, Medi
Cybernetics, San Diego, USA). Elastin breaks of the media were counted at 400x and neointi-
mal index (NI, intima / (intima + lumen), %) was measured at 100x magnification. Area of the
intima as region of interest (ROI) was defined semi-automatically using imaging software.
Transmission Electron Microscopy
The specific structure of Marfan and WT vessels after adenovirus transduction was displayed
by transmission electron microscopy. TwoWT and two mgR/mgR thoracic aortas were har-
vested and transfected with Ad.hTIMP-1 as described above. After 7 and 30 minutes of incuba-
tion each one WT and one Marfan aorta was flushed intensively with cold saline and perfused
with fixation solution (2% formaldehyde, 2% glutaraldehyde, 2mMMgCl2 in 66 mM caco-
dlyate-buffer, pH 7.2). After placing the aortas in fixation solution, tissue was cut in 0.5mm
thick slices. Immersion-fixation was continued over night at 4°C in EM-fix. Tissue was post-
fixed in buffered OsO4, dehydrated by ethanol of increasing concentration (50%, 75%, 100%)
an embedded in epoxide (11.5 g Glycidether, 6g DDSA, 7.5g NMA, 850 μl BDMA, all from
Sigma, St. Louis, Missouri, USA). Sections were cut at nominal thickness 60 nm, post-stained
by uranyl and lead and observed with a Zeiss EM 910 at 80 kV (Zeiss, Jena, Germany).
Statistical Analysis
All statistical evaluation was performed using SPSS (IBM SPSS Statistics 19; IBM Corporation,
Armonk, NY, USA). If the data were normally distributed, a T-test was applied, otherwise the
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non-parametric Mann-Whitney U-test was performed. Statistical significance was accepted at
p0.05, and results of p0.001 were described as highly significant. All photos were random-
ized and blinded before independent evaluation by two different researchers. For each aortic
graft numbers of elastin breaks were counted and NI was measured in four different pictures,
each of different aortic slides to calculate means. For Evaluation of Albumin perfusion test 9
photos of each media were taken in different parts of the aorta and mean relative brightness
was ascertained in a blinded fashion.
Results
Transduction of Ad.hTIMP-1 Results in Overexpression of hTIMP-1 and
Consecutive Reduced MMP Activity
Western blot analysis demonstrated overexpression of hTIMP-1 after adenoviral gene transfer
in HEK-293 cells. The hTIMP-1 protein migrated at an apparent molecular weight of 25 to
30kDa. The molecular mass of TIMP-1 ranges vom 28.5–34 kDa according to the degree of gly-
cosylation [23]. Furthermore, immunohistochemical examination of aortic grafts illustrated
overexpression of hTIMP-1 30 days after transduction and surgery (Fig 1B). We did not detect
hTIMP in untreated Marfan grafts after implementation of the same staining protocol (nega-
tive control). The hTIMP-1 transgene was located in every part of the vessel but is concentrated
in the intimal and adventitial regions. Collagen in situ zymography confirmed successful inhi-
bition of MMP1, -2, -3, -9, and -13 in aortic grafts 30 days after treatment with Ad.hTIMP-1.
Qualitatively, the untreated mgR/mgR aorta converted more collagen substrate during incuba-
tion than mgR/mgR aorta previously transfected with Ad.h-TIMP-1 (Fig 1C).
Overexpression of hTIMP-1 Does Not Alter Number of Elastin Breaks
Representing the Vascular Phenotype of Marfan Mice
We expected to reduce elastolysis by hTIMP-1 overexpression. The number of elastin breaks
within the media was endpoint for quantification of elastolysis (measured in breaks per view
field at 400x magnification). As expected untreated WT (Fig 2) and Ad.hTIMP-1 treated WT
grafts did not show an increased level of elastin breaks after 30 days (Table 1). The mean quan-
tity of elastin breaks in untreated mgR/mgR grafts was 12.25, which represented significantly
more than in native or Ad.TIMP-1-treated WT grafts (p = 0.001 and p = 0.001; Table 2). Sur-
prisingly, Ad.hTIMP-1 treated (12.13 breaks) and Ad-β-Gal.-treated mgR/mgR grafts (14.68
breaks) did not differ statistically in the quantity of elastin breaks (p = 0.383). Therefore, we
conclude that overexpression of hTIMP-1 by adenoviral transduction did not reduce elastolysis
of Marfan aorta (compared to native mgR/mgR Marfan mice, p = 0.902).
Aorta of Marfan but Not Wildtype Mice Develop Intimal Hyperplasia after
Adenoviral Gene Therapy
The neointimal index was calculated as parameter for intimal hyperplasia (IH), which conceiv-
ably could be induced either by the virus or the procedure or both (Fig 3 and Table 3). WT
grafts (untreated as well as Ad.hTIMP-1-transduced) did not show prominent stenosis of the
lumen (1.24% and 0.00%, p = 0.002, Table 2). Untreated mgR/mgR aortas developed a small
stenosis of 5.7% which is statistically larger compared to Ad.hTIMP-1 transduced WT
(p = 0.026) but not to native WT aorta (p = 0.053). In contrast Ad.hTIMP-1 and Ad.β-Gal per-
fused mgR/mgR grafts displayed the severest hyperplasia of the intima resulting in major ste-
nosis of the aortic lumen (43.45% and 23.5%, p = 0.038). Compared to the untreated mgR/mgR
Marfan aorta that did not have contact with adenovirus, the NI was significantly larger in Ad.
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Fig 1. Overexpression of hTIMP-1 after Ad.hTIMP-1 Transduction. A: Western blot analysis for proof of
hTIMP-1 overexpression after transdudtion with Ad.hTIMP-1 in HEK-293 cells. Ad.hTIMP-1 transduced cells
(HEK+) demonstrated a strong signal for hTIMP-1 above the 25kDa lane (left), whereas untreated native
HEK-293 (HEK-) showed weaker lane for hTIMP-1 (right). B: Immunohistochemistry of hTIMP-1 in aortic
grafts after transduction with Ad.hTIMP-1 (100x magnification). Even 30 days after transduction sufficient
transgene expression is detected in all layers of the aorta (left). Untreated marfan aorta was used as negative
control (right). C: In situ zymography (100x magnification) of untretead (upper row) and Ad.hTIMP-1 treated
mgR/mgRmarfan grafts (lower row). Increase of light emission represents conversion of collagen substrate
during incubation (24h) by Matrix-Metalloproteinases (left: pre incubation). After Ad.TIMP-1 transduction and
incubation (down, right) we saw less MMP activity than in untreated aortas (up, right).
doi:10.1371/journal.pone.0148012.g001
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Fig 2. Elastolysis is not Reduced in MgR/mgRMarfan Grafts after Adenoviral Overexpression of hTIMP-1. A-E: Van Gieson stain (400x magnification)
of 30-day old mouse aortic grafts (n = 7) after heterotopic infrarenal transplantation. Untreated WT (A) and Ad.hTIMP-1 treated WT (E) show intact elastin
layers (1.4 and 0.1 breaks per view field). Native mgR/mgRmarfan grafts (B, 12.3 breaks) as well as Ad.β-Gal. (C, 14.7 breaks) and Ad.hTIMP-1 (D, 12.1
breaks) transduced mgR/mgRmarfan grafts present severe elastolysis within the aortic media. F: Mean number of elastin breaks within the aortic media
(n = 7, counted at 400x magnification): Compared to untreated mgR/mgR and Ad.β-Gal transduced mgR/mgR aortas elastin degradtation was not reduced
by andeoviral transduction of Ad.hTIMP-1 (p = 0.902 and p = 0.383). WT, wildtype aorta; mgR/mgR, Marfan aorta; Ad.β-Gal, treated with adenovirus coding
for β- galactosidase; Ad.hTIMP-1, treated with adenovirus coding for human TIMP-1. *p-value0.05; ** p-value0.001, calculated using Mann-Whitney-
U-Test.
doi:10.1371/journal.pone.0148012.g002
Table 1. Number of elastin breaks within the aortic media 30 days after transplantation.
n = 7 WT Marfan Marfan + Ad.β-Gal Marfan + Ad.hTIMP-1 WT + Ad.hTIMP-1
elastin breaks per view ﬁeld (400x magniﬁcation)* 1.43 12.25 14.68 12.12 0.07
WT, wildtype aorta; vs., versus; Marfan, Marfan aorta; Ad.β-Gal, treated with adenovirus coding for β- galactosidase; Ad.hTIMP-1, treated with adenovirus
coding for human TIMP-1.
doi:10.1371/journal.pone.0148012.t001
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hTIMP-1-treated (p<0.001) and borderline significant in Ad.β-Gal-treated mgR/mgR aorta
(p = 0.053).
Inflammation and Monocyte Invasion after Adenoviral Contact in Marfan
Tissue
H&E staining of grafts visualized signs of severe inflammation and a large amount of
recruited inflammatory cells after adenoviral transduction only in the mgR/mgR aorta, but
not in the WT aorta (Fig 4A–4D). In detail we determined the invasion of monocytes by
immunohistochemical staining in the aorta of mgR/mgR mice after transduction of adenovi-
rus. (Fig 4E–4H).
Endothelial Barrier of Marfan Aorta Is Permeable for Large Proteins and
Shows Alterations of the Basement Membrane
Pictures taken by transmission electron microscopy demonstrated substantial differences
between the WT and the MFS samples. (Fig 5A–5D): After incubation with Ad.TIMP-1 for 30
minutes mgR/mgR aorta impressed by a very flimsy and bulked basement membrane (BM).
The basolateral space was unusually wide and detached. In contrast, the transduced WT aorta
presented a common structure of the BM and a compact basolateral space. Based on our TEM
results we hypothesized a substantial endothelial dysfunction in native MFS tissue. In order to
proof our hypothesis we additionally performed an albumin perfusion test on native, virus-
untreated and not transplanted MFS andWT tissue. Incubation with fluorochrome-labeled
albumin revealed a substantial defect of the endothelial barrier for large proteins in native, not
virus-exposed Marfan tissue: Compared to untreated WTmice aorta, untreated mgR/mgR
Marfan aorta showed significant more light emission that correlates with increased albumin
diffusion through the endothelial barrier (p = 0.037, Fig 5E–5H, Table 4).
Discussion
Inflammation and degradation of elastin fiber networks by MMPs are known to play a crucial
role in the formation of aortic aneurysms in patients with MFS and the mgR/mgR Marfan
Table 2. Statistical evaluation of morphometric analysis.
p-values* elastin breaks neointimal Index
WT vs. WT Ad.hTIMP-1 0.002 0.534
WT vs. Marfan 0.001 0.053
WT vs. Marfan Ad.hTIMP-1 0.001 0.001
WT vs. Marfan Ad.β-Gal 0.001 0.004
Marfan Ad.hTIMP-1 vs. Marfan 0.902 0.001
Marfan Ad.hTIMP-1 vs. Marfan Ad.β-Gal 0.383 0.038
Marfan Ad.hTIMP-1 vs. WT Ad.hTIMP-1 0.001 0.001
Marfan vs. WT Ad.hTIMP-1 0.001 0.017
Marfan vs. Marfan Ad.β-Gal 0.165 0.053
Marfan Ad.β-Gal vs. WT Ad.hTIMP-1 0.001 0.001
Neointimal index, neointima / (neointima + lumen) in %, WT, wildtype aorta; vs., versus; Marfan, Marfan aorta; Ad.β-Gal, treated with adenovirus coding
for β- galactosidase; Ad.hTIMP-1, treated with adenovirus coding for human TIMP-1.
*p-values were calculated using Mann-Whitney-U-Test, p-values 0.05 were considered as signiﬁcant and p-values 0.001 as highly signiﬁcant.
doi:10.1371/journal.pone.0148012.t002
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Fig 3. Intimal Hyperplasia in mgR/mgRMarfan Grafts after Adenoviral Transduction. A-E: Van Gieson
stain of 30-day old mouse aortic grafts after heterotopic infrarenal transplantation (40x magnification). WT
grafts point out almost no (A, NI = 1.24%) and native mgR/mgRMarfan grafts just a minor stenosis of the
lumen (NI = 5.7%). Marfan graft after treatment with adenoviral vectors coding for β-galactosidase (C,
NI = 23.05%) and hTIMP-1 (D, 43,45%) display intimal hyperplasia narrowing the lumen (p = 0.038). In
contrast, wildtype vessels do not present intimal hyperplasia after transduction with Ad.hTIMP-1 (E,
NI = 0.00%). F: Mean of neointimal index in 30-day old transplanted aortas (n = 7). Compared to native mgR/
mgR grafts NI is significant greater in Ad.hTIMP-1 (p = 0.026) and borderline significant in Ad.β-Gal.
transduced mgR/mgR grafts (p = 0.053). WT, wildtype aorta; mgR/mgR, Marfan aorta; Ad.β-Gal, treated with
adenovirus coding for β-galactosidase; Ad.hTIMP-1, treated with adenovirus coding for human TIMP-1; NI,
neointimal index, neointima / (neointima + lumen). *p-value0.05; ** p-value0.001, calculated using
Mann-Whitney-U-Test (n = 7).
doi:10.1371/journal.pone.0148012.g003
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mouse model [1, 17]. Based on aneurysms caused by structural weakness of the aortic wall,
spontaneous dissections or even ruptures are still the major life-threatening complication in
MFS [2]. Broad inhibition of MMPs—for instance by overexpression of TIMP-1—therefore
may represent a useful approach to reduce MMP induced inflammation and elastolysis within
the aortic media. The non-specific MMP inhibitor doxycycline has demonstrated its potential
to reduce aortic aneurysm formation in mgR/mgR mice [16]. Overexpression of TIMP-1 in
vessels by adenoviral transduction has been performed successfully before in different study
models with the approach to inhibit inflammation [24, 25]. Adenoviral gene transfer of
hTIMP-1 and, surprisingly, also of MMP-3 resulted in reduced development of intimal hyper-
plasia in vein grafts [26]. Therefore the concept of MMP-inhibition for reduction of MMP-trig-
gered elastolysis in the murine mgR/mgR aorta seems promising. We are the first to describe
adenoviral hTIMP-1 transduction of murine mgR/mgR aorta. In this work we demonstrated
sufficient expression of hTIMP-1 even 30 days after adenoviral transduction by immunohisto-
chemical staining. Furthermore, collagen in situ zymography revealed efficient inhibition of
MMP1, -2, -3, -9 and -13 in aortic grafts by overexpressed hTIMP-1. Therefore, we expected to
reduce elastin defragmentation of mgR/mgR aorta by overexpression of hTIMP-1. Surpris-
ingly, we instead observed signs of severe inflammation and hyperplasia of the intima in mgR/
mgR aorta after contact with the adenovirus. Elastin breaks within the media of Marfan aorta
were not reduced as expected, presumably due to an overshooting immune response. Interest-
ingly, the WT aorta showed no signs of inflammation and lumen narrowing after the same pro-
tocol of transgene transduction. In our study adenoviral transfected mgR/mgR mice revealed
even higher NI if Ad.hTIMP-1 was applied. We can just assume, but inhibition of MMP seems
to play a crucial role in formation of intimal hyperplasia. An ancient study showed reduced
neointimal formation in vein grafts after MMP-3 overexpression [26]. Based on that hypothesis
overactivity of MMP inhibitors, such as TIMPs, might even provoke the vessel stenosis under
special conditions.
In contrast to our findings, overexpression of hTIMP-1 has shown its potential to reduce
inflammatory processes and intimal hyperplasia: In an in vitro model overexpression of
hTIMP-1 prevents migration of smooth muscle cells, which is known to be one cellular mecha-
nism for intimal hyperplasia [22]. Another study revealed that adenoviral mediated hTIMP-1
decreases intimal hyperplasia in saphenous vein grafts [24]. In contrast, an overshooting
immune response (invasion of inflammatory cells, intimal hyperplasia) after application of too
high titers of adenovirus was described as well [27]. To avoid the well-described primary toxic-
ity of adenoviral vectors, we applied a protocol with reduced viral titers as described before
[26]. Because all animals were generated in the same breed and have an identical genetic back-
ground, an immune response against the graft cannot explain our findings. Instead, it seems
that the Marfan aorta does not tolerate the same concentration of adenovirus as the WT aorta
does. This surprising observation can only be explained by specific characteristics of Marfan
tissue on a cellular and molecular level. Our tissue examinations by transmission electron
microscope and the albumin diffusion demonstrate functional defects and morphologic
Table 3. Neointimal index as parameter for stenosis within aortic grafts 30 days after transplantation.
n = 7 WT Marfan Marfan + Ad. β-Gal Marfan + Ad.hTIMP-1 WT + Ad.hTIMP-1
Neointimal Index (NI, %)* 1.2 5.7 23.5 43.5 0.0
Neointimal index, neointima / (neointima + lumen) in %; WT, wildtype aorta; Marfan, Marfan aorta; Ad.β-Gal, treated with adenovirus coding for β-
galactosidase; Ad.hTIMP-1, treated with adenovirus coding for human TIMP-1.
*arithmetical mean
doi:10.1371/journal.pone.0148012.t003
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Fig 4. Inflammation in mgR/mgRMarfan grafts. A-D: H&E staining at 40x magnification. Untreated (B) as
well as Ad.hTIMP-1 (C) and Ad.β-Gal (D) treated mgR/mgRMarfan vessels present invasion of inflammatory
cells (blue). No substantial cellular inflammation is seen in untreatedWT grafts (A). E-H: F4/80
immunohistochemical staining (40x magnification) to display monocyte infiltration (red) and counterstain with
DAPI to visualize nuclei (blue). Ad.hTIMP- (E) and Ad.β-Gal. transduced mgR/mgRMarfan graft (F) show
intense invasion of monocytes within the adventitia and neointima, whereas no relevant amount of
monocytes is observed in virus untreatedWT (G) and mgR/mgRMarfan aorta (H). WT, wildtype aorta; mgR/
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alterations of the endothelial cell layer both in virus-exposed and native not virus-treated tis-
sue. After contact to adenovirus the basolateral space is abnormally wide and loose. Addition-
ally, albumin diffusion through the endothelial barrier of virus untreated and not transplanted
Marfan aortas is significantly increased compared to the native WT aortas.
A defect of the endothelium is a risk factor for the formation of intimal hyperplasia [28].
Circulating cells are able to pass the defect barrier and to bind to the exposed subendothelial
matrix. The pathological mechanism is comparable with the etiology of thromboembolic pro-
cesses [28–30]. Furthermore, it is known that coagulation disorders in viral infectious diseases,
such as Dengue Hemorrhagic Fever, are associated with a defect and dysfunction of the endo-
thelium [31]. However, because of the evident different pathophysiologic mechanisms, we do
not think that virus-endothelium interactions are the major pathophysiologic trigger for aneu-
rysm formation in Marfan syndrome. Otherwise we would expect to see aortic atherosclerosis
and thromboembolic processes instead of aneurysm formation as major vascular pathology in
Marfan syndrome. But in our specific experimental setting with high local virus titers, it is
plausible that the development of neointima in mgR/mgR aortas after contact with adenovirus
is related to a defect of the endothelium.
The role of endothelial dysfunction in MFS has been discussed before: Wilson et al.
described a selective loss of flow mediated endothelium-dependent vasodilation in the brachial
artery of Marfan patients [32]. Besides endothelial (dys-) function, the morphological specifics
of the Marfan endothelium have not been discussed in the literature yet. However, endothelial
hyperpermeability and paracellular flux play a major role in vascular inflammation [33]. Mac-
rophage chemotaxis is part of cellular inflammation in Marfan tissue and is stimulated by
fibrillin-fragments [34, 35]. Not only dysfunction but also the here described morphological
changes of the endothelial barrier in Marfan aorta might play a crucial role for cellular inflam-
mation that enables macrophages to enter the aortic media where fibrillin-fragments are
located. The finding, that indomethacin treatment is capable of reducing elastin degradation in
mgR/mgR Marfan mice by inhibition of inflammatory infiltration underlines this explanatory
approach [36]. It is necessary to note that the most important receptor for adenovirus-cell
interaction, named CAR ("Cocksackie and adenovirus receptor"), is located behind the barrier
of epithelial tissue on the basolateral surface. Only a small amount of applied adenoviruses is
able to enter the cell on the apical surface [37, 38]. Although this receptor has not been
described in Marfan tissue yet, it was found in endothelial cells of rat carotids [39]. Consecu-
tively, a significant defect of the endothelial barrier might allow adenovirus to bind basolateral
CAR and induce overshooting inflammation. This represents a coherent explanation why Mar-
fan aorta shows vulnerability against adenovirus and is permeable for large blood standing pro-
teins and inflammatory cells.
In conclusion, we demonstrated overexpression of hTIMP-1 after adenoviral mediated gene
transfer in HEK-293 cells in vitro and in cells of murine thoracic aorta after heterotopic infrare-
nal transplantation. However, due to severe intimal hyperplasia it was not possible to show the
reduction of elastin degradation within the media of the mgR/mgR aorta. Surprisingly, an over-
shooting immune response after adenoviral transfection was only observed in the Marfan
aorta. Furthermore, the mgR/mgR aorta showed a severe integrity defect of the endothelium
and increased permeability for albumin. Therefore, our findings underline the crucial role of
the endothelium barrier in the pathogenesis of MFS. Further research is necessary to trace this
promising but so far almost neglected approach. A better understanding of the abnormal
mgR, Marfan aorta; Ad.β-Gal, treated with adenovirus coding for β- galactosidase; Ad.hTIMP-1, treated with
adenovirus coding for human TIMP-1.
doi:10.1371/journal.pone.0148012.g004
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Fig 5. Defect of the Endothelial Barrier in Marfan Tissue. A-D: Analysis of wildtype (WT; A, B) and Marfan
aortas (C, D) after transduction of Ad.hTIMP-1 by transmission electron microscope. At 400x magnification
characteristic degradation of ECM compounds are found in the Marfan aorta. (C). The integrity of the
endothelial-ECM transition is lost in Marfan tissue (D, 16000x magnification) and the basolateral space
imposes irregularly wide (D, red arrow) compared to WTaorta (B). Adventitia (a), endothelial cell (e), elastin
fiber (f), vessel lumen (l), aortic media (m). E-H: Fluorescence microscopy after perfusion with fluorochrome-
labeled bovine albumin. In untreatedWT aortas light emission is concentrated at the endothelial layer and the
adventitia (E, 100x magnification). Albumin is not able to pass endothelial layer (F, 400x magnification).
Native mgR/mgRMarfan aorta displays a significant permeability of the endothelial barrier for albumin (G,
100x; H, 400x). Compared to WT tissue albumin fluorescence (relative brightness) within the media is
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endothelium in MFS may offer new therapeutic options directed against the vascular pheno-
type in MFS.
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